As of June 30, 2026, GMO Product Platform INC. carries a market capitalization of 6.26B, placing it among publicly traded companies globally. Its enterprise value stands at 403.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.26B |
| Enterprise Value | 403.91M |
GMO Product Platform INC.'s next confirmed earnings release is scheduled for November 12, 2026.
| Earnings Date | 11/12/2026 |
As of June 30, 2026, GMO Product Platform INC. has 4.40M shares outstanding.
| Shares Outstanding | 4.40M |
These figures are as of June 30, 2026.
| PB Ratio | 2.52 |
| P/TBV Ratio | 3.99 |
As of June 30, 2026, GMO Product Platform INC. maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.17 |
| Quick Ratio | 0.90 |
| Debt / Equity | 35.94 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 195.50 |
As of the close on October 22, 2026, GMO Product Platform INC.'s stock has declined approximately 25.82% over the past 52 weeks. The 50-day moving average sits at 1,535.32, while the 200-day moving average is 1,670.57.
| 52-Week Price Change | -25.82% |
| 50-Day Moving Average | 1,535.32 |
| 200-Day Moving Average | 1,670.57 |
As of June 30, 2026, GMO Product Platform INC. holds 6.78B in cash and equivalents against 901.32M in total debt, resulting in a net debt position of -1.40B. Total book value stands at 2.48B, with working capital of 1.24B providing operational flexibility.
| Cash & Cash Equivalents | 6.78B |
| Total Debt | 901.32M |
| Net Debt | -1.40B |
| Equity (Book Value) | 2.48B |
| Book Value Per Share | 563.90 |
| Working Capital | 1.24B |
Already premium?